Home Newsfeeds Piper Sandler Downgrades Globus Medical to Neutral

Piper Sandler Downgrades Globus Medical to Neutral

Piper Sandler analyst Matt O'Brien downgrades Globus Medical (NYSE:GMED) from Overweight to Neutral.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Piper Sandler analyst Matt O’Brien downgrades Globus Medical (NYSE:GMED) from Overweight to Neutral.

HeartCore Expands Partnership With Heart-Tech Health To Implement AI Capabilities Into Its Med-Tech Platform.

By Benzinga Newsdesk

April 22, 8:44 AM

HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development

HTCR

Darden Restaurants To Gain 7%? Here Are 5 Other Price Target Changes For Friday

By Lisa Levin

September 23, 7:26 AM

Wedbush raised the price target on Darden Restaurants, Inc. (NYSE: DRI) from $122 to $134. Wedbush analyst Nick Setyan maintained the stock with a Neutral rating. Darden shares fell 4.4% to close at $125.45 on Thursday.

CRM